Cargando…

Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy

BACKGROUND: Glycyrrhetinic acid (GA) is the most important ingredient in licorice due to its outstanding anti-inflammatory activity and wide application in the medicine and cosmetics industries. Contemporary industrial production of GA by acid hydrolysis of glycyrrhizin which was extracted from Glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Caixia, Su, Xinyao, Sun, Mengchu, Zhang, Mengting, Wu, Jiajia, Xing, Jianmin, Wang, Ying, Xue, Jianping, Liu, Xia, Sun, Wei, Chen, Shilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540369/
https://www.ncbi.nlm.nih.gov/pubmed/31138208
http://dx.doi.org/10.1186/s12934-019-1138-5
_version_ 1783422600625520640
author Wang, Caixia
Su, Xinyao
Sun, Mengchu
Zhang, Mengting
Wu, Jiajia
Xing, Jianmin
Wang, Ying
Xue, Jianping
Liu, Xia
Sun, Wei
Chen, Shilin
author_facet Wang, Caixia
Su, Xinyao
Sun, Mengchu
Zhang, Mengting
Wu, Jiajia
Xing, Jianmin
Wang, Ying
Xue, Jianping
Liu, Xia
Sun, Wei
Chen, Shilin
author_sort Wang, Caixia
collection PubMed
description BACKGROUND: Glycyrrhetinic acid (GA) is the most important ingredient in licorice due to its outstanding anti-inflammatory activity and wide application in the medicine and cosmetics industries. Contemporary industrial production of GA by acid hydrolysis of glycyrrhizin which was extracted from Glycyrrhiza plants, is not environment-friendly and devastates farmland since the Glycyrrhiza rhizomes grow up to 10 m underground. RESULTS: In this study, GA was produced through metabolically engineering Saccharomyces cerevisiae by introducing the entire heterogeneous biosynthetic pathway of GA. Codon optimized CYP88D6 and CYP72A154, combined with β-AS (β-amyrin synthase encoding gene) and the NADPH-cytochrome P450 reductase gene of Arabidopsis thaliana were introduced into S. cerevisiae. The resulting strain (Y1) produced 2.5 mg/L of β-amyrin and 14 μg/L of GA. The cytochrome b5 from G. uralensis (GuCYB5) was identified and the introduction of this novel GuCYB5 increased the efficiency of GA production by eightfold. The joint utilization of the GuCYB5 gene along with 10 known MVA pathway genes from S. cerevisiae were overexpressed in a stable chromosome integration to achieve higher GA production. Using the combined strategy, GA concentration improved by 40-fold during batch fermentation. The production was further improved to 8.78 mg/L in fed-batch fermentation, which was increased by a factor of nearly 630. CONCLUSIONS: This study first investigated the influence of carbon flux in the upstream module and the introduction of a newly identified GuCYB5 on GA production. The newly identified GuCYB5 was highly effective in improving GA production. An integrated strategy including enzyme discovery, pathway optimization, and fusion protein construction was provided in improving GA production, achieving a 630 fold increase in GA production. The metabolically engineered yeast cell factories provide an alternative approach to glycyrrhetinic acid production, replacing the traditional method of plant extraction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-019-1138-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6540369
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65403692019-06-03 Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy Wang, Caixia Su, Xinyao Sun, Mengchu Zhang, Mengting Wu, Jiajia Xing, Jianmin Wang, Ying Xue, Jianping Liu, Xia Sun, Wei Chen, Shilin Microb Cell Fact Research BACKGROUND: Glycyrrhetinic acid (GA) is the most important ingredient in licorice due to its outstanding anti-inflammatory activity and wide application in the medicine and cosmetics industries. Contemporary industrial production of GA by acid hydrolysis of glycyrrhizin which was extracted from Glycyrrhiza plants, is not environment-friendly and devastates farmland since the Glycyrrhiza rhizomes grow up to 10 m underground. RESULTS: In this study, GA was produced through metabolically engineering Saccharomyces cerevisiae by introducing the entire heterogeneous biosynthetic pathway of GA. Codon optimized CYP88D6 and CYP72A154, combined with β-AS (β-amyrin synthase encoding gene) and the NADPH-cytochrome P450 reductase gene of Arabidopsis thaliana were introduced into S. cerevisiae. The resulting strain (Y1) produced 2.5 mg/L of β-amyrin and 14 μg/L of GA. The cytochrome b5 from G. uralensis (GuCYB5) was identified and the introduction of this novel GuCYB5 increased the efficiency of GA production by eightfold. The joint utilization of the GuCYB5 gene along with 10 known MVA pathway genes from S. cerevisiae were overexpressed in a stable chromosome integration to achieve higher GA production. Using the combined strategy, GA concentration improved by 40-fold during batch fermentation. The production was further improved to 8.78 mg/L in fed-batch fermentation, which was increased by a factor of nearly 630. CONCLUSIONS: This study first investigated the influence of carbon flux in the upstream module and the introduction of a newly identified GuCYB5 on GA production. The newly identified GuCYB5 was highly effective in improving GA production. An integrated strategy including enzyme discovery, pathway optimization, and fusion protein construction was provided in improving GA production, achieving a 630 fold increase in GA production. The metabolically engineered yeast cell factories provide an alternative approach to glycyrrhetinic acid production, replacing the traditional method of plant extraction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-019-1138-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-28 /pmc/articles/PMC6540369/ /pubmed/31138208 http://dx.doi.org/10.1186/s12934-019-1138-5 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wang, Caixia
Su, Xinyao
Sun, Mengchu
Zhang, Mengting
Wu, Jiajia
Xing, Jianmin
Wang, Ying
Xue, Jianping
Liu, Xia
Sun, Wei
Chen, Shilin
Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy
title Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy
title_full Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy
title_fullStr Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy
title_full_unstemmed Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy
title_short Efficient production of glycyrrhetinic acid in metabolically engineered Saccharomyces cerevisiae via an integrated strategy
title_sort efficient production of glycyrrhetinic acid in metabolically engineered saccharomyces cerevisiae via an integrated strategy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540369/
https://www.ncbi.nlm.nih.gov/pubmed/31138208
http://dx.doi.org/10.1186/s12934-019-1138-5
work_keys_str_mv AT wangcaixia efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT suxinyao efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT sunmengchu efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT zhangmengting efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT wujiajia efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT xingjianmin efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT wangying efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT xuejianping efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT liuxia efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT sunwei efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy
AT chenshilin efficientproductionofglycyrrhetinicacidinmetabolicallyengineeredsaccharomycescerevisiaeviaanintegratedstrategy